Medtronic Plc
(NYSE : MDT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 1.49%489.621.0%$560.18m
ABTAbbott Laboratories 0.52%109.570.8%$518.23m
DHRDanaher Corp. 1.85%239.250.7%$504.07m
MDTMedtronic Plc -1.71%106.080.6%$435.58m
ALGNAlign Technology, Inc. 2.24%464.716.4%$416.43m
ISRGIntuitive Surgical, Inc. 2.19%727.372.3%$388.68m
BSXBoston Scientific Corp. -1.52%36.301.0%$324.44m
DXCMDexCom, Inc. -7.74%385.657.9%$299.71m
BDXBecton, Dickinson & Co. 0.98%244.371.0%$267.91m
QDELQuidel Corp. 2.61%270.297.7%$245.00m
BAXBaxter International, Inc. 1.85%81.491.8%$200.57m
SYKStryker Corp. -0.31%214.081.3%$200.10m
VARVarian Medical Systems, Inc. 0.33%173.039.1%$190.84m
EWEdwards Lifesciences Corp. -0.82%77.440.4%$173.71m
IDXXIDEXX Laboratories, Inc. 2.62%440.203.8%$143.68m

Company Profile

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist Cardiac Rhythm and Heart Failure, Coronary and Structural Heart, and Aortic and Peripheral Vascular divisions. The Minimally Invasive Technologies Group segment comprises Surgical Innovations and Respiratory, Gastrointestinal, and Renal divisions. The Restorative Therapies Group contains Spine, Brain, Specialty Therapies, and Pain Therapies divisions. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.